Identification of four novel T cell autoantigens and personal autoreactive profiles in multiple sclerosisKarolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Therapeut Immune Design, S-17176 Stockholm, Sweden..
Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Therapeut Immune Design, S-17176 Stockholm, Sweden..
Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Therapeut Immune Design, S-17176 Stockholm, Sweden..
Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, S-17177 Stockholm, Sweden..
Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Therapeut Immune Design, S-17176 Stockholm, Sweden..
Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Neuroimmunol Unit, S-17176 Stockholm, Sweden..
Univ Zurich, Univ Hosp Zurich, Neuroimmunol & MS Res Sect NIMS, Neurol Clin, CH-8091 Zurich, Switzerland..
KTH, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH), Protein Science.
Karolinska Inst, Karolinska Univ Hosp, Dept Clin Neurosci, Div Neurol, S-17176 Stockholm, Sweden..
Karolinska Inst, Karolinska Univ Hosp, Dept Clin Neurosci, Div Neurol, S-17176 Stockholm, Sweden..
Karolinska Inst, Karolinska Univ Hosp, Dept Clin Neurosci, Div Neurol, S-17176 Stockholm, Sweden..
Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Neuroimmunol Unit, S-17176 Stockholm, Sweden..
Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Neuroimmunol Unit, S-17176 Stockholm, Sweden.;Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, S-75237 Uppsala, Sweden..
Univ Zurich, Univ Hosp Zurich, Neuroimmunol & MS Res Sect NIMS, Neurol Clin, CH-8091 Zurich, Switzerland..
Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Neuroimmunol Unit, S-17176 Stockholm, Sweden..
Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Neuroimmunol Unit, S-17176 Stockholm, Sweden..
Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Neuroimmunol Unit, S-17176 Stockholm, Sweden..
Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Therapeut Immune Design, S-17176 Stockholm, Sweden..
Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Neuroimmunol Unit, S-17176 Stockholm, Sweden..
Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Therapeut Immune Design, S-17176 Stockholm, Sweden..
Show others and affiliations
2022 (English)In: Science Advances, E-ISSN 2375-2548, Vol. 8, no 17, article id eabn1823Article in journal (Refereed) Published
Abstract [en]
Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS), in which pathological T cells, likely autoimmune, play a key role. Despite its central importance, the autoantigen repertoire remains largely uncharacterized. Using a novel in vitro antigen delivery method combined with the Human Protein Atlas library, we screened for T cell autoreactivity against 63 CNS-expressed proteins. We identified four previously unreported autoantigens in MS: fatty acid-binding protein 7, prokineticin-2, reticulon-3, and synaptosomal-associated protein 91, which were verified to induce interferon-gamma responses in MS in two cohorts. Autoreactive profiles were heterogeneous, and reactivity to several autoantigens was MS-selective. Autoreactive T cells were predominantly CD4(+) and human leukocyte antigen-DR restricted. Mouse immunization induced antigen-specific responses and CNS leukocyte infiltration. This represents one of the largest systematic efforts to date in the search for MS autoantigens, demonstrates the heterogeneity of autoreactive profiles, and highlights promising targets for future diagnostic tools and immunomodulatory therapies in MS.
Place, publisher, year, edition, pages
American Association for the Advancement of Science (AAAS) , 2022. Vol. 8, no 17, article id eabn1823
National Category
Immunology in the medical area
Identifiers
URN: urn:nbn:se:kth:diva-312687DOI: 10.1126/sciadv.abn1823ISI: 000790076700032PubMedID: 35476434Scopus ID: 2-s2.0-85128887004OAI: oai:DiVA.org:kth-312687DiVA, id: diva2:1660498
Note
QC 20220524
2022-05-242022-05-242026-02-27Bibliographically approved